BNP Paribas downgraded Zealand Pharma (ZLDPF) to Neutral from Outperform with a DKK 275 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma downgraded to Market Perform from Outperform at William Blair
- Zealand Pharma downgraded to Neutral from Overweight at Cantor Fitzgerald
- Zealand Pharma downgraded to Hold from Buy at SEB Equities
- Zealand Pharma downgraded to Hold from Buy at Nordea
- Zealand Pharma Earnings Call Signals High‑Stakes Expansion